Related Experiment Video
Updated: Sep 8, 2025

Author Spotlight: Exploring Huotan Jiedu Tongluo Decoction as an Antihypertensive Drug
Published on: May 17, 2024
Homocysteine in coronavirus disease (COVID-19): a systematic literature review
Giovanni Carpenè1, Davide Negrini1, Brandon M Henry2
1Section of Clinical Biochemistry and School of Medicine, University of Verona, Verona, Italy.
Insights
Increased homocysteine levels may predict severe outcomes in COVID-19 patients. This systematic review suggests hyperhomocysteinemia is linked to unfavorable disease progression in coronavirus disease 2019.
Area of Science:
- Cardiovascular Medicine
- Infectious Diseases
- Biochemistry
Background:
- Coronavirus disease 2019 (COVID-19) is associated with a prothrombotic state.
- Homocysteine is a potential biomarker for thrombotic diseases.
Purpose of the Study:
- To provide an updated overview of the role of hyperhomocysteinemia in COVID-19 progression.
- To explore the association between homocysteine levels and COVID-19 severity.
Main Methods:
- Systematic review of studies published between 2019 and present.
- Electronic search conducted in Medline (PubMed interface).
- Keywords used: "COVID-19" OR "SARS-CoV-2" AND "homocysteine".
Main Results:
- Three studies involving 694 hospitalized COVID-19 patients were included.
- Mean homocysteine values were consistently higher in severe COVID-19 patients compared to non-severe cases.
- A positive weight mean difference of 1.75 μmol/L (95%CI, 1.26-2.25 μmol/L; p=0.011) was observed.
Conclusions:
- Increased homocysteine levels may serve as a predictive marker for unfavorable COVID-19 progression.
- Further research is needed to confirm the role of homocysteine in COVID-19 outcomes.
Objectives:
Coronavirus disease 2019 (COVID-19) is a life-threatening infectious disorder characterized by a sustained prothrombotic state. Since homocysteine is a potential biomarker of thrombotic diseases, the aim of this article is to provide an updated overview on the possible role played by hyperhomocysteinemia in influencing an unfavorable COVID-19 progression.
Methods:
We carried out an electronic search in Medline (PubMed interface) using the keywords ("COVID-19" OR "SARS-CoV-2") AND "homocysteine", between 2019 and the present time, with no language restrictions, to identify all articles which explored the concentration of homocysteine in COVID-19 patients with or without unfavorable disease progression.
Results:
Three studies, totaling 694 hospitalized COVID-19 patients, were included in our systematic review. Overall, the differences between the mean homocysteine values in non-severe vs. severe COVID-19 patients were always positive (i.e., 15.1%, 24.1% and 22.8%, generating a positive weight mean difference of 1.75 μmol/L (95%CI, 1.26-2.25 μmol/L; p=0.011), which translates into a cumulative difference of approximately ∼1.2 μmol/L.
Conclusions:
Despite the limited evidence that has been garnered so far, increased homocysteine levels may be a potentially useful marker for predicting the risk of unfavorable progression in patients with COVID-19.
More Related Videos
08:36Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
Published on: April 19, 2024
06:29Comparing Objective Conjunctival Hyperemia Grading and the Ocular Surface Disease Index Score in Dry Eye Syndrome During COVID-19
Published on: May 25, 2022
Related Concept Videos
Conjugated Proteins
Nucleoproteins are protein complexes that contain nucleic acids, categorized as deoxyribonucleoproteins (DNPs) or ribonucleoproteins (RNPs) respectively. The nucleosome is a typical example of a DNP where nuclear DNA is associated with histone proteins. The major antigen for the Covid-19 virus SARS-CoV is an RNP that is critical...
Hypertension III: Clinical Manifestations and Diagnostic Studies
Single Nucleotide Polymorphisms-SNPs
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Hypertension and Regulation of Blood Pressure
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...